跳至主要内容
临床试验/CTRI/2024/03/063729
CTRI/2024/03/063729尚未招募不适用

A clinical study in assessing the antithyroglobulin antibody levels in hashimotos thyroiditis using Murphy repertory

未提供1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年3月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
The efficacy of Homoeopathic medicines in reducing the Anti-thyroglobulin antibody level in Hashimoto’s thyroiditis will be proved before and after an interval of 6 months of the treatment.

研究概览

简要总结

This study aims to assess the effectiveness of homeopathic medicines in reducing anti-thyroglobulin antibody levels in patients diagnosed with Hashimoto’s thyroiditis, an autoimmune condition leading to hypothyroidism. With a focus on a sample size of 30 cases from outpatient and inpatient departments, demographic data, symptoms, and laboratory values including thyroid-stimulating hormone (TSH) and anti-thyroglobulin antibody (anti-Tg) levels will be evaluated. The intervention involves homeopathic remedies based on individual symptomatology. The primary objective is to analyze the impact of homeopathic treatment on anti-thyroglobulin antibody levels, with secondary objectives including the assessment of symptomatic improvement using Zulewski clinical score and the construction of an alphabetical repertory on thyroid disorders. Expected outcomes include demonstrating the efficacy of homeopathic medicines in reducing thyroglobulin antibody levels, symptomatic improvement, and the development of a comprehensive repertory for thyroid disorders.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • Patients suffering from Hashimoto’s thyroiditis with elevated TSH, anti-Thyroglobulin Ab. Female patients will be included.
  • Patients between 18-60 years of age.

排除标准

  • Pregnant, post-partum and nursing women will be excluded.
  • Known cases of other autoimmune disorders.
  • Known cases of thyroid malignancy.

结局指标

主要结局

The efficacy of Homoeopathic medicines in reducing the Anti-thyroglobulin antibody level in Hashimoto’s thyroiditis will be proved before and after an interval of 6 months of the treatment.

时间窗: The efficacy of Homoeopathic medicines in reducing the Anti-thyroglobulin antibody level in Hashimoto’s thyroiditis will be proved before and after an interval of 6 months of the treatment. | Cases will be evaluated for age, sex, occupation, symptoms presented, values of anti-thyroglobulin antibody (anti-Tg), thyroid peroxidase antibodies and TSH will be considered for statistical analysis and to derive the result, thereby validating the study.

Cases will be evaluated for age, sex, occupation, symptoms presented, values of anti-thyroglobulin antibody (anti-Tg), thyroid peroxidase antibodies and TSH will be considered for statistical analysis and to derive the result, thereby validating the study.

时间窗: The efficacy of Homoeopathic medicines in reducing the Anti-thyroglobulin antibody level in Hashimoto’s thyroiditis will be proved before and after an interval of 6 months of the treatment. | Cases will be evaluated for age, sex, occupation, symptoms presented, values of anti-thyroglobulin antibody (anti-Tg), thyroid peroxidase antibodies and TSH will be considered for statistical analysis and to derive the result, thereby validating the study.

次要结局

  • The symptomatic improvement of the patient with hypothyroidism assessed by Zulewski clinical score will reveal the efficacy of Murphy repertory in the treatment of Hashimoto’s thyroiditis.(An alphabetical repertory will be constructed on thyroid disorders.)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Reshma JR

Sarada Krishna Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验

Studying antithyroglobulin antibodies in hashimotos... | 临床试验